COVID-19
Conditions
Interventions
None listed
Sponsors
SHIONOGI & Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthcare workers at Tokyo Rinkai Hospital who meet all of the following criteria are eligible for this study. 1)Healthcare workers who tested positive for SARS-CoV-2 at Tokyo Rinkai Hospital from Jun 2023 to Sep 2023 2)Healthcare workers who received ensitrevir according to the package insert or who did not receive anti-SARS-CoV-2 drugs. 3)Healthcare workers who can obtain all the following required data If ensitrevir was administered, the start and end date of ensitrevir. SARS-CoV-2 positive test result Quantitative antigen test results on the scheduled day of return to work Number of days from date of onset of COVID-19 to return to work
Exclusion criteria
Exclusion criteria: Healthcare workers at Tokyo Rinkai Hospital who meet any of the following criteria will be excluded from the study. 1)Healthcare workers who were not treated according to the package insert 2)Healthcare workers who received anti-SARS-CoV-2 drugs other than ensitrevir 3)Healthcare workers who refused to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average number of days from onset of symptoms to return to work. | — |
Secondary
| Measure | Time frame |
|---|---|
| Virus residual rate proportion (antigen quantitative test >100 pg / ml) on the planned date of return to work for the re-examination. | — |
Countries
Japan
Contacts
Public ContactYasuko Ariwa
SHIONOGI & Co., Ltd. Medical Affair
Outcome results
None listed